The role of engineering in healthcare has been highlighted by the Royal Academy of Engineering as part of its campaign This is Engineering to raise awareness of the breadth of careers in engineering, and help address the significant engineering skills and diversity shortfall in the UK.
The UK's Department of Health and Social Care has today announced the launch of a pilot programme for the new NHSX, working with clinicians and policymakers in cancer and mental health. If successful, the approach will be rolled out across the NHS.
NextGen Jane, a diagnostics startup focused on reproductive health, has raised a $9 million Series A round led by Material Impact, with the participation of Access Industries, Viking Global Investors, Liminal Ventures, and several angels.
Renal insufficiency is an expensive condition to treat due to the high cost of hospital dialysis treatment. Peripal AG, a Swiss startup, has received approval for the European market for its PeriSafe device for at-home dialysis.
A joint report published today by the King's Fund, the Nuffield Trust, and the Health Foundation, Closing the gap, highlights the growing shortage of staffing in the NHS, and associated difficulties in achieving the goals of the NHS Long Term Plan.
Doctolib, the French digital health startup, has closed a €150 million funding round at a valuation of over €1 billion. The round was led by General Atlantic, with the participation of Bpifrance, Eurazeo, Kernel and Accel.
Unite Us has raised $35 million in its Series B investment round led by Oak HC/FT. Other investors include Town Hall Ventures, Define Ventures, Scout Ventures, Luminate, and New York Ventures. The funds will be used to fuel the company's growth.
Liva Healthcare has closed an €8 million investment round from three new investors: MIG, Santo Venture Capital and Digital Health Ventures. The investment will enable Liva Healthcare to scale up with existing clients, expand further geographically and continue its technological innovation.
The Organ Donation Act has today passed into law, and from spring 2020 all adults in England will be considered potential donors unless they opt out or are excluded.
TriNetX, a clinical research network, has closed its Series D investment round of $40 million led by Merck GHIF. The funding will be used for international expansion and product development.